Publicis Health's acquisition of BBK will help it leverage patient clinical trail data to better understand real world behavior.

Pub­li­cis Health snaps up R&D mar­ket­ing group track­ing re­al-world clin­i­cal tri­als – and pa­tient sen­ti­ment

As biotechs move to adopt phar­ma-style mar­ket­ing, Pub­li­cis Health is buy­ing a biotech mar­ket­ing and clin­i­cal tri­al en­roll­ment com­pa­ny. Its

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.